Kathryn Ruddy is an Oncology physician affiliated with Mayo Clinic. OpenAlex indexes 706 publications with 21,536 citations (h-index 60); ClinicalTrials.gov lists 3 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
200 1st St SW
Rochester, MN 559050001
Telephone
507-284-2511Provider last certified this registry record 20 Aug 2020.
Clinical trials
- Low Dose Aspirin for the Prevention of Postpartum Related Breast Cancer
Sponsor: Mayo Clinic
- Dexamethasone in Reducing Everolimus-Induced Oral Stomatitis in Patients With Cancer
Sponsor: Alliance for Clinical Trials in Oncology
- Multi-epitope Folate Receptor Alpha Peptide Vaccine, GM-CSF, and Cyclophosphamide in Treating Patients With Triple Negative Breast Cancer
Sponsor: Academic and Community Cancer Research United
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- TerSera Therapeutics LLCProgram year20231 payment
- Gilead Sciences, Inc.Program year20211 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
NIH funding
2 NIH research awards on record, funded 2019–2024 per NIH RePORTER. The latest:
- TrAstuzumab Cardiomyopathy Therapeutic Intervention with Carvedilol (TACTIC) Trial
Mayo Clinic Rochester
FY2024$773,975R01CA233610 - TrAstuzumab Cardiomyopathy Therapeutic Intervention with Carvedilol (TACTIC) Trial
Mayo Clinic Rochester
FY2023$798,417R01CA233610 - TrAstuzumab Cardiomyopathy Therapeutic Intervention with Carvedilol (TACTIC) Trial
Mayo Clinic Rochester
FY2022$825,573R01CA233610
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Interrupting Endocrine Therapy to Attempt Pregnancy after Breast Cancer
New England Journal of Medicine
2023 - Breast Cancer in Adolescent and Young Adult Women Under the Age of 40 Years
JCO Oncology Practice
2021
Similar KOLs
Other experts from the same institution or the same specialty.
S Rajkumar, MD
Mayo Clinic
Bradley Boeve, MD
Mayo Clinic
Rick Nishimura, MD
Mayo Clinic
Victor Montori, MD
Mayo Clinic
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”